Health In Tech insider report: 7,000 restricted shares awarded to CTO

Rhea-AI Filing Summary

Health In Tech, Inc. (HIT) reporting person Imran Yousuf, Chief Technology Officer and Director, received a grant of 7,000 restricted Class A common shares on 08/15/2025. The restricted shares are subject to vesting tied to two separate product launches: 50% vests monthly over 12 months after the first specified program is successfully launched and operational, and the remaining 50% vests monthly over 12 months after the second specified program is successfully launched and operational. Following the grant the reporting person beneficially owns 107,000 shares (comprised of 100,000 shares and 7,000 restricted shares). The filing excludes 100,000 options to purchase Class A common stock.

Insights

Financial Analyst

TL;DR: Routine restricted-stock grant to CTO ties compensation to product launches; no immediate dilution but signals long-term incentive alignment.

The grant of 7,000 restricted Class A shares to the CTO is a compensation event linked to operational milestones rather than cash pay. It does not show an immediate cash impact or share issuance at public markets; the filing reports beneficial ownership rising to 107,000 shares. Excluded from the beneficial ownership tally are 100,000 options, which remain outstanding but were not transacted here. For investors, this is a governance and incentive disclosure rather than a material corporate financing or divestiture.

Corporate Governance Expert

TL;DR: Vesting tied to product launches aligns executive incentives with company milestones; standard Section 16 reporting completed.

The restricted-share award includes milestone-based vesting conditions that delay recognition until specific products are operational. The filing fulfills Section 16 reporting for an insider grant and clarifies ownership composition. The structure limits immediate transferability until vesting events occur, which is consistent with retention and performance alignment practices. No amendments, departures, or exceptional governance items are disclosed in this record.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Yousuf Imran Mohammed

(Last) (First) (Middle)

701 S. COLORADO AVE

SUITE 1

(Street)

STUART FL 34994

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Health In Tech, Inc. [ HIT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/15/2025		A		7,000(1)	A	$0	107,000(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. Fifty percent (50%) of the shares of restricted stock granted to the reporting person shall vest in equal monthly installments over a twelve (12) month period commencing on the date that the first of two specified programs being developed by the Company is successfully launched and fully operational in the marketplace, and the remaining fifty percent (50%) shall vest in equal monthly installments over a twelve (12) month period commencing on the date that the other specified program being developed by the Company is successfully launched and fully operational in the marketplace.

2. Includes 100,000 shares of Class A Common Stock and 7,000 shares of restricted stock. Excludes 100,000 options to purchase shares of Class A Common Stock.

	/s/ Imran Yousuf	08/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Health In Tech (HIT) report for Imran Yousuf?

The filing reports a grant of 7,000 restricted Class A common shares to Imran Yousuf on 08/15/2025.

How many shares does the reporting person beneficially own after the transaction?

The reporting person beneficially owns 107,000 shares, consisting of 100,000 shares plus the 7,000 restricted shares granted.

Are there any options mentioned in the Form 4 for HIT?

Yes. The filing explicitly excludes 100,000 options to purchase Class A common stock from the beneficial ownership total.

What are the vesting conditions for the restricted shares?

Vesting is milestone-based: 50% vests monthly over 12 months after the first specified program is launched and operational; the remaining 50% vests monthly over 12 months after the second specified program is launched and operational.

What role does the reporting person hold at HIT?

The reporting person is listed as Chief Technology Officer and a Director of the company.